BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11576217)

  • 41. Inhibitory Fcγ receptor engagement drives adjuvant and anti-tumor activities of agonistic CD40 antibodies.
    Li F; Ravetch JV
    Science; 2011 Aug; 333(6045):1030-4. PubMed ID: 21852502
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines.
    Harrop JA; Reddy M; Dede K; Brigham-Burke M; Lyn S; Tan KB; Silverman C; Eichman C; DiPrinzio R; Spampanato J; Porter T; Holmes S; Young PR; Truneh A
    J Immunol; 1998 Aug; 161(4):1786-94. PubMed ID: 9712045
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanism of enhanced antigen presentation by B cells activated with anti-mu plus interferon-gamma: role of B7-2 in the activation of naive and memory CD4+ T cells.
    Morokata T; Kato T; Igarashi O; Nariuchi H
    Eur J Immunol; 1995 Jul; 25(7):1992-8. PubMed ID: 7542599
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polyclonal activation of immature B cells by preactivated T cells: the role of IL-4 and CD40 ligand.
    Brines RD; Klaus GG
    Int Immunol; 1993 Nov; 5(11):1445-50. PubMed ID: 7505108
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Engaging Ly-6A/Sca-1 triggers lipid raft-dependent and -independent responses in CD4
    Lang MA; Jenkins SA; Balzano P; Owoyele A; Patel A; Bamezai AK
    Immun Inflamm Dis; 2017 Dec; 5(4):448-460. PubMed ID: 28660664
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Functional Specialty of CD40 and Dendritic Cell Surface Lectins for Exogenous Antigen Presentation to CD8(+) and CD4(+) T Cells.
    Yin W; Gorvel L; Zurawski S; Li D; Ni L; Duluc D; Upchurch K; Kim J; Gu C; Ouedraogo R; Wang Z; Xue Y; Joo H; Gorvel JP; Zurawski G; Oh S
    EBioMedicine; 2016 Mar; 5():46-58. PubMed ID: 27077111
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CD40-mediated stimulation contributes to lymphocyte proliferation, antibody production, eosinophilia, and mastocytosis during an in vivo type 2 response, but is not required for T cell IL-4 production.
    Lu P; Urban JF; Zhou XD; Chen SJ; Madden K; Moorman M; Nguyen H; Morris SC; Finkelman FD; Gause WC
    J Immunol; 1996 May; 156(9):3327-33. PubMed ID: 8617957
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proliferative capacity of senescent lymphocytes. II. Monoclonal antibody stimulation of mucosal and systemic lymphocytes via T cell activation molecules, CD3 epsilon, T cell receptor V beta 8 chain, and phosphatidylinositol-linked anchored receptors THY-1 and LY-6A.2/TAP.
    Green-Johnson JM; Szewczuk MR
    Reg Immunol; 1990-1991; 3(6):323-35. PubMed ID: 1983438
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A subset of CD4+ memory T cells contains preformed CD40 ligand that is rapidly but transiently expressed on their surface after activation through the T cell receptor complex.
    Casamayor-Palleja M; Khan M; MacLennan IC
    J Exp Med; 1995 Apr; 181(4):1293-301. PubMed ID: 7699321
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation requirements of cloned inducer T cells. I. Differential inhibition by anti-L3T4 or anti-I-A is determined by the accessory cell population.
    DeKruyff R; Clayberger C; Cantor H; Dorf ME
    J Immunol; 1985 Oct; 135(4):2243-8. PubMed ID: 3897372
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of a monoclonal antibody, anti-6C2, which is involved in the interaction of CD4 T helper cells and activated B cells.
    Torimoto Y; Sugita K; Weinberg DS; Dang NH; Donahue C; Letvin NL; Schlossman SF; Morimoto C
    J Immunol; 1991 Apr; 146(7):2176-84. PubMed ID: 1706389
    [TBL] [Abstract][Full Text] [Related]  

  • 52. B cell-mediated down-regulation of IFN-gamma and IL-12 production induced during anti-tumor immune responses in the tumor-bearing state.
    Wijesuriya R; Maruo S; Zou JP; Ogawa M; Umehara K; Yamashita M; Ono S; Fujiwara H; Hamaoka T
    Int Immunol; 1998 Aug; 10(8):1057-65. PubMed ID: 9723691
    [TBL] [Abstract][Full Text] [Related]  

  • 53. B-cell expansion in the presence of the novel 293-CD40L-sCD40L cell line allows the generation of large numbers of efficient xenoantigen-free APC.
    Ivanov R; Aarts T; Hagenbeek A; Hol S; Ebeling S
    Cytotherapy; 2005; 7(1):62-73. PubMed ID: 16040385
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decreased CD154 expression by neonatal CD4+ T cells is due to limitations in both proximal and distal events of T cell activation.
    Jullien P; Cron RQ; Dabbagh K; Cleary A; Chen L; Tran P; Stepick-Biek P; Lewis DB
    Int Immunol; 2003 Dec; 15(12):1461-72. PubMed ID: 14645155
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heat-stable antigen is a costimulatory molecule for CD4 T cell growth.
    Liu Y; Jones B; Aruffo A; Sullivan KM; Linsley PS; Janeway CA
    J Exp Med; 1992 Feb; 175(2):437-45. PubMed ID: 1346270
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of CD40-CD40 ligand interaction in human T cell-B cell collaboration.
    Nishioka Y; Lipsky PE
    J Immunol; 1994 Aug; 153(3):1027-36. PubMed ID: 7517971
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activated T cells induce rapid CD83 expression on B cells by engagement of CD40.
    Kretschmer B; Kühl S; Fleischer B; Breloer M
    Immunol Lett; 2011 May; 136(2):221-7. PubMed ID: 21277328
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Splenic NK1.1-negative, TCR alpha beta intermediate CD4+ T cells exist in naive NK1.1 allelic positive and negative mice, with the capacity to rapidly secrete large amounts of IL-4 and IFN-gamma upon primary TCR stimulation.
    Moodycliffe AM; Maiti S; Ullrich SE
    J Immunol; 1999 May; 162(9):5156-63. PubMed ID: 10227987
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Induction of germinal center B cell markers in vitro by activated CD4+ T lymphocytes: the role of CD40 ligand, soluble factors, and B cell antigen receptor cross-linking.
    Lahvis GP; Cerny J
    J Immunol; 1997 Aug; 159(4):1783-93. PubMed ID: 9257841
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of SM201, an anti-hFcγRIIB antibody not interfering with ligand binding that mediates immune complex dependent inhibition of B cells.
    Rieth N; Carle A; Müller MA; ter Meer D; Direnberger C; Pohl T; Sondermann P
    Immunol Lett; 2014 Aug; 160(2):145-50. PubMed ID: 24472604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.